BPC-157 vs Ketoconazole
Extensively Studied vs FDA Approved
synergistic Mechanism-based · 50% BPC-157 reduces inflammation while Ketoconazole promotes tissue repair. Reducing inflammation creates a more favorable environment for healing.
Molecular Data
BPC-157 Ketoconazole
Weight 1,419.53 Da 531.43 Da
Half-life <30 minutes Topical application stays local with minimal systemic absorption
Chain 15 amino acids —
Type Pentadecapeptide Synthetic imidazole antifungal
Key Benefits
BPC-157
01 Accelerated tendon, ligament, muscle, and bone healing
02 Localized tissue repair with direct targeting
03 Superior bioavailability
04 Anti-inflammatory effects
05 Angiogenesis promotion
06 Gastric and intestinal protection
Ketoconazole
01 Disrupts DHT binding at the follicle level with topical application
02 Reduces Malassezia colonization and scalp inflammation associated with hair loss
03 Negligible systemic absorption when used as a shampoo
04 FDA-approved and widely available over the counter (1%) or by prescription (2%)
05 Part of the established "big 3" hair loss protocol with finasteride and minoxidil
06 Treats concurrent seborrheic dermatitis and dandruff while addressing hair loss
07 Simple to incorporate into existing shower routines
Dosing Protocols
BPC-157
250-500mcg / Once or twice daily
Tendon/Joint healing 250-500 mcg 1-2x daily
Serious injury 500-1000 mcg 2x daily
General healing 250-500 mcg 1-2x daily
Maintenance 250 mcg 1x daily
Ketoconazole
1-2% shampoo / 2-3x per week
Side Effects
BPC-157
Mild injection site redness
Injection site irritation
Possible mild digestive adjustment (oral)
Ketoconazole
Scalp dryness with regular use
Mild scalp irritation or itching at application site
Changes in hair texture (temporary dryness or coarseness)
Contraindications
Active cancer (due to angiogenic effects)
Pregnancy or breastfeeding
Blood thinners (consult doctor due to angiogenesis)
WADA prohibited for competitive athletes
Known hypersensitivity to ketoconazole or any imidazole antifungal
Open wounds or severely broken skin on the scalp
Oral ketoconazole is contraindicated in liver disease (not applicable to shampoo use)
Research Evidence
BPC-157 Ketoconazole
Status Extensively Studied FDA Approved
References 8 studies 4 studies
Latest July 2025 —
FDA Approved No Yes
This comparison is for educational and research purposes only. Consult a healthcare professional before use.